iBio, Inc. - 8-K Filing
iBio highlights preclinical data showing IBIO-610 preserves muscle when combined with semaglutide in NHP study (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
iBio highlights preclinical data showing IBIO-610 preserves muscle when combined with semaglutide in NHP study (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)